EP2373172
Hindranir á HCV NS5A
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.12.2009EP published:
17.7.2013EP application number:
09831077.4
EP translation filed:
17.10.2013Grant published:
15.11.2013EPO information:
European Patent Register
Max expiry date:
1.12.2029Expiry date:
1.12.2022
Title:
INHIBITORS OF HCV NS5A
Timeline
Today
2.12.2009EP application
17.7.2013EP Publication
17.10.2013Translation submitted
15.11.2013Registration published
1.12.2022Expires
Owner
Name:
Presidio Pharmaceuticals, Inc.Address:
1700 Owens Street Suite 585, 94158, San Francisco, CA, US
Inventor
Name:
ZHONG, MinAddress:
San Francisco, CA, US
Name:
LI, LepingAddress:
San Francisco, CA, US
Agent
Name:
KIPA ABAddress:
Pósthólf 1065, Drottninggatan 11, SE
Priority
Number:
182958 PDate:
1.6.2009Country:
US
Number:
119723 PDate:
3.12.2008Country:
US
Number:
173590 PDate:
28.4.2009Country:
US
Number:
214881 PDate:
28.4.2009Country:
US
Number:
182952 PDate:
1.6.2009Country:
US
Classification
Categories:
A01N 57/00, A61K 31/675, C07D 403/14, C07D 405/14, C07D 417/14, C07D 413/14, C07D 471/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 20.11.2013
Expires: 1.12.2014
Payer: G. H. Sigurgeirsson
Number: 6
Paid: 11.11.2014
Expires: 1.12.2015
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 28.12.2015
Expires: 1.12.2016
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 10.11.2016
Expires: 1.12.2017
Payer: Árnason Faktor
Number: 9
Paid: 9.11.2017
Expires: 1.12.2018
Payer: Árnason Faktor
Number: 10
Paid: 6.11.2018
Expires: 1.12.2019
Payer: Árnason Faktor
Number: 11
Paid: 7.11.2019
Expires: 1.12.2020
Payer: Árnason Faktor
Number: 12
Paid: 6.11.2020
Expires: 1.12.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.11.2021
Expires: 1.12.2022
Payer: Árnason Faktor ehf.